Biotech Grand Prix 2025
Standing up for solutions to society's problemsBiotechnology, healthcare, medicine, drug discovery, medical devices, research tools, etc.
We implement the technologies and thoughts of entrepreneurs and researchers in the biotech field into society together.
News

- Agritech Grand Prix
- Ecotech Grand Prix
- Grand Prix
- Deep Tech Grand Prix
- News
- Biotech Grand Prix
- Food Tech Grand Prix
- Marintec Grand Prix
- Lifetech Grand Prix

- Agritech Grand Prix
- Ecotech Grand Prix
- Grand Prix
- Deep Tech Grand Prix
- News
- Biotech Grand Prix
- Food Tech Grand Prix
- Marintec Grand Prix
- Lifetech Grand Prix

- Grand Prix
- Biotech Grand Prix

- Grand Prix
- News
- Biotech Grand Prix
Outline of the event
- point (e.g. of a statement)
- Scientific and technological "seeds" are being created in universities, research institutes, and corporate laboratories, but it takes a lot of effort before they sprout into practical applications. The "Tech Planter," organized by LIVERNESS and its partners, is an ecosystem designed to serve as a planter to discover these seeds and help them sprout into business. The Biotech Grand Prix is a program aimed at discovering and fostering technology seeds and entrepreneurs in the real tech field (biotechnology, healthcare, medicine, drug discovery, medical devices, research tools, etc.).
Related Grand Prix :. List of Biotech Grand Prix - subject (of taxation, etc.)
-
- Those who have a vision to change the world or improve the world based on the technological seeds in the real tech field and have a will to establish or develop a new business.
- Individuals and teams are both welcome to participate, even before incorporation.
- No limitation on the number of years of establishment, even if you are already a corporation. Even if you are close to mass production or PMF establishment, if you are planning to collaborate with partner companies, etc., it is acceptable.
- Application Theme
- Biotechnologies supporting the environment, energy, food, agriculture, medicine and health, etc.
- Application period
- Monday, December 2, 2024 - Friday, July 4, 2025 23:59
- Screening Criteria
-
A panel of judges composed of LIVERNESS and its partners will review the following items
- 01novelty (patentability)
- 02feasibility
- 03Overseas Expansion Capabilities
- 04Are you going to change the world?
- 05passion
- commendation
- Grand Prize: (300,000 yen cash prize + right to receive 5 million yen business investment) 1
Corporate Prize: (200,000 yen) Approximately 10 prizes will be awarded.
Schedule
- 12/2[MON]
-
Entry Start
this way (direction close to the speaker or towards the speaker)Please register as a member and fill out the web form to apply. We also hold information sessions at universities and on an individual basis to encourage determination to enter and to teach tips on how to prepare documents. Please feel free to contact us for more information.
- 6/7[SAT]
-
kickoff
RIVANES and its partners, as well as entered teams, will meet and mingle.
Business consultation and partnership development with each other will be available. Participation or lack of participation on the day of the event will not be considered.
- 7/4[FRI].
-
1st round: Application Screening
A panel of judges composed of LIVERNESS and its partners will review the documents.
You will be asked to submit information about your team, skills, passions, and vision for the future via web form and video.
All applicants will be notified of the screening results and provided with feedback on their applications.
In addition, individual interviews (also online) for presentation review will be conducted for those who wish to participate.
- 8monthfirst 10 days of month
-
Finalists determined
Interviews will be held for applicants who pass the document screening to brush up their presentations for the final round.
In addition, meetings can be set up with partner companies for the purpose of business consultation and developing partnerships.
- 10/18[SAT]
-
Biotech Grand Prix
The 12 finalist teams that pass the document screening will be screened for presentation.
- 10Month~
-
Cooperation Discussion
After the Demo Day, the contact point between the venture and LIBANES will continue to be open for discussions on commercialization.
We handle a wide range of start-up issues, from incorporation to prototype development, financing, R&D, and more.
In addition, collaborative matching between ventures and partner companies has become more active to support business development.
Partners
asset
- ASSET01Riverness Communicator
- ASSET02Partners
- ASSET03Professional Supporter
- ASSET04superfactory group
Support
- SUPPORT01Organize the purpose and vision of starting a business
- SUPPORT02Brush up on your presentation
- SUPPORT03Providing opportunities for business company collaboration
- SUPPORT04Support for R&D and prototype development
- SUPPORT05Support for knowledge and IP strategies
- SUPPORT06finance
Grand Prix Outline
- Grand Prix Name
- Biotech Grand Prix 2025
- Location
- center of a garage (1-16-3 Yokogawa, Sumida-ku, Tokyo)
- Date & Time
- Saturday, October 18, 2025, 13:00-19:00
- Application period
- Monday, December 2, 2024 - Friday, July 4, 2025 23:59
- Participation Target
- Held on a closed, pre-registration basis (finalists, partner companies, professional supporters, Super Factory Group)
- organizing
- Leave a Nest Co., Ltd.
- timeline
-
- 12:30-13:00
- inauguration
- 13:00-13:30
- Greetings from the Organizer
- 13:30-17:00
- Presentation (Presenter①~⑫)
- 17:00-17:50
- Review Time
- 17:50-19:00
- Announcement of Judging Results and Award Ceremony
- 19:00-19:30
- (cultural) exchange meeting
judge
finalist
-
- Regenesome Corporation
- Representative] Kengo Suzuki
Biotechnology Solves the Challenges of Aging
The RongevityTech business uses exosomes and other biotechnologies to solve health issues on Earth and in space due to aging. -
- Cellufilm Research Institute Co.
- Representative] Kenji Ito
OKUDAKE" static culture bag
OKUDAKE, a static culture bag made of highly gas permeable film, enables static culture of microbial cultures that require aeration. By eliminating physical stress caused by shaking, it brings out the potential of cultures and expands the possibilities of biotechnology. -
- Craftide Inc.
- Representative] Shunsuke Oishi
Peptide Farming Opens the Door to Sustainable Agriculture
Peptide Farming, which utilizes naturally degradable peptides, draws out the power of plants and applies it to agriculture. It contributes to the realization of environmentally harmonized agriculture by accelerating nutrient absorption and increasing tolerance to high temperatures and drought stress. -
- Miyako Marker Institute, Inc.
- Representative] Takahiko Okada
Building a New Concept in Health Care with a Palm-sized Urine Analyzer
Urine discharges molecular markers that reflect the intestinal environment, natural immune cell activity, and mental status. We have developed a technology to measure these markers with a "small palm-sized testing device" and bring a new self-check tool for creating health to the world. -
- Mos-Q
- Representative] TERUTSUKI Daigo
Challenging Disaster Sites with Human Odor Sensors that Utilize Mosquito Sense of Smell
Develop a bio-hybrid odor sensor that applies the mosquito's sense of smell to detect human-specific odors with high sensitivity. The aim is to develop a new technology to locate people in need of rescue at disaster sites where image sensors do not work well, such as in poor visibility or under rubble, by using smell as a clue. -
- Pyrozyme
- Representative] Yuichi Koga
Providing new value with the world's best thermostable protease
Proteins have unlimited possibilities, and based on mass production technology for proteases (proteolytic enzymes), which are rare enzymes that work even at 100°C, we are overturning the conventional wisdom that enzymes are weak against heat and realizing new manufacturing through "enzymatic reactions at 100°C". -
- QualitiZyme
- Representative] Chiaki Matsuzaki
Technology for producing highly functionalized enzymes that enable recycling
Enzymes are needed for the manufacture of products in a variety of industries, including medicine, food, chemical industry, and agriculture. We are innovating the efficiency, cost, and environmental impact of manufacturing by making natural enzymes more functional (improved stability and functionality) so that they can be used industrially. -
- SoLAVi
- Representative] Yusho Nakamuta
Learning from Electric Eels Development of Biocompatible Carbon Battery
Learning from the power-generating organs of electric eels, we are creating a new battery that does not use metals. The challenge is to develop next-generation batteries with biocompatibility, flexibility, and natural degradability in a layered hydrogel structure made of graphene oxide and bio-carbon, with an eye toward medical/wearable applications. -
- SPM Maneuver
- Representative] Takuya Kubo
Innovative Separants: Diversified Modality Pharmaceutical Separation and Purification
The proprietary sponge monolith (SPM) has micron-sized through holes and is suitable as a separation field for new drug modalities. We aim to update this to the gold standard for pharmaceutical separation and build a new pharmaceutical production system. -
- TerrAccel
- Representative] Toru Takahashi
A Clean Future Created by Electron Beams, TerraQLean
Applying superconducting acceleration technology for particle physics experiments and the International Linear Collider, we have developed an electron beam sterilizer that is 1/10th the size and 1/5th to 1/10th the price of conventional ones. It replaces ethylene oxide gas sterilization, which is feared to be environmentally destructive and carcinogenic, and realizes safe and secure medical treatment. -
- gash
- Representative] Sotaro Fujii
Revalorization of Citrus Residues by Lactobacillus Fermentation
To make effective use of the residue of citrus peels scheduled for disposal, we will develop fermentation technology using GABA high-producing lactic acid bacteria and aim to apply it as a new food material. -
- physiola
- Representative] Ken Takahashi
Drug Toxicity Visible! Future medicine with organ chips
The "skeleton twin" is a technology that makes each patient's drug response and toxicity risk transparent and reproduces the patient's response on a human organ chip as a digital twin. This technology will reduce medical costs and realize highly accurate and personalized medicine.